Market Research Logo

Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region

Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021) - By Vaccine Type (Anti- Bacterial, Anti-Viral); Diseases-Types (TB, Typhoid, Influenza, Others), By Region (North America, Europe, APAC, ROW); By Country (USA, Canada, UK, France, India, China)

Executive Summary

Surging old age population, rising polluted drinking water, development of bioterrorism combined with rising technological development in vaccine industry, growing awareness towards individual health along with initiative taken by various government and non-government institutions have been driving the demand for anti-infective vaccines.Rising incidences of typhoid, TB, hepatitis and other virus borne diseases will drive the market for anti-infective vaccines market. Further, rising concerns over bioterrorism due to biological weapons along with increasing focus on the immunization programmes for prevention of diseases have been contributing in the growth of Anti Infective Vaccines.

Among the types of bacterial diseases, market is expected to be driven by typhoid and TB, mainly due to high number of cases in developing regions. However, antiviral vaccines will continue to generate major revenue due to increases R&D expenses along with rising number cases for various diseases like Influenza and ZIKA virus in developed regions.While developed regions will continue to dominate the market in terms of revenue, emerging nations are expected to respond to the market optimistically due to the developing healthcare infrastructure and rising focus on healthcare among the growing middle class population along with escalating expenditure on immunization programmes by various NGO’s.

Global Anti- infective vaccine Market is forecasted to grow at a CAGR of 5.88% during 2016 – 2021F, on account of rising incidences of typhoid, TB, hepatitis and Influenza among the growing population across the globe. North America region remains the major market followed by Europe in the actual period, while APAC and ROW region will witness strong growth in the forecast period.

According to Azoth Analytics research report, Global Anti-Infective Vaccines Market – Analysis By Disease Type (Bacterial, Viral), By Region, By Country: Opportunities and Forecasts (2016-2021), Global Anti-Infective Vaccine market is projected to exhibit a CAGR of over ~5.88% during 2016 - 2021.

Scope of the Report

The report provides Segmentation by Vaccine Type

  • Anti- Bacterial
  • Anti- Viral
Segmentation by Sub - Type
  • Anti- Bacterial- Diseases Type, TB Typhoid and Other’s
  • Anti- Viral Type- Diseases Type, Hepatitis, Influenza and Other’s
Coverage by Region
  • North America
  • Europe
  • Asia Pacific
  • ROW
Coverage by Country
  • USA
  • Canada
  • UK
  • France
  • India
  • China
Customization of the Report

The report could be customized according to the client’s specific research requirements. No additional cost will be required to pay for limited additional research.


1. Research Methodology
2. Executive Summary
3. Strategic Recommendation
3.1. Escalate the focus on the Asia Pacific Region
3.2. Focus on R&D
4. Global Anti-infective Vaccines Market: Product Overview
5. Global Anti-infective Vaccines Market: Growth and Forecast
5.1 Global Anti-infective Vaccines Market
5.1.1. By Value (Historic 2011-15)
Table 1: Global Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
5.1.2. By Value ( Forecast 2016E-2021F)
Table 2: Global Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
6. Global Anti-Bacterial Vaccines Market: Growth and Forecast
6.1 Global Anti-Bacterial Vaccines Market
6.1.1. By Value (Historic 2011-15)
Table 3: Global Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
6.1.2 By Value (Forecast 2016E-2021F)
Table 4: Global Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
7. Global Anti-Viral Vaccines Market: Growth and Forecast
7.1 Global Anti-Viral Vaccines Market
7.1.1 By Value (Historic 2011-15)
Table 5: Global Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
7.1.2 By Value( Forecast 2016E-2021F)
Table 6: Global Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
8. Global Anti-infective Vaccines Market - By Disease
8.1 Global Typhoid Vaccines Market
8.1.1. By Value-Actual (2015)
Table 7: Global Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
8.1.2. By Value-Forecast(2021)
Table 8: Global Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
8.2 Global Tuberculosis Vaccines Market
8.2.1. By Value-Actual(2015)
Table 9: Global Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
8.2.2. By Value -Forecast(2021)
Table 10: Global Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
8.3 Global Other Anti-Bacterial Vaccines Market
8.3.1. By Value-Actual(2015)
Table 11: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
8.3.2 By Value- Forecast (2021)
Table 12: Global Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
8.4 Global Influenza Vaccines Market
8.4.1. By Value-Actual(2015)
Table 13: Global Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
8.4.2 By Value- Forecast (2021)
Table 14: Global Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
8.5 Global Hepatitis Vaccines Market
8.5.1 By Value-Actual(2015)
Table 15: Global Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
8.5.2 By Value- Forecast (2021)
Table 16: Global Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
8.6 Global Other Anti-Viral Vaccines Market
8.6.1 By Value-Actual(2015)
Table 17: Global Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
8.6.2 By Value- Forecast (2021)
Table 18: Global Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
9. Global Anti-Infective vaccines- Pipeline Analysis
9.1 Typhoid Vaccines
9.2 Tuberculosis Vaccines
9.3 Tetanus & Diptheria Vaccines
9.4 Other Anti-Bacterial Vaccines
9.5 Influenza Vaccines
9.6 Hepatitis Vaccines
9.7 Polio Vaccines
9.8 Other Anti-Viral Vaccines
10. North America Anti-infective Vaccines Market
10.1 By Value-Actual(2015)
Table 19: North America Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
10.2 By Value- Forecast (2021)
Table 20: North America Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
10.3 North America Anti-Bacterial Vaccines Market
10.3.1 By Value-Actual(2015)
Table 21: North America Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
10.3.2 By Value- Forecast (2021)
Table 22: North America Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
10.4 North America Anti-Viral Vaccines Market
10.4.1 By Value-Actual(2015)
Table 23: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
10.4.2 By Value Forecast ( 2016-2021)
Table 24: North America Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
11. North America Anti-Infective Vaccines Market- By Disease
11.1 North America Typhoid Vaccines Market
11.1.1 By Value-Actual(2015)
Table 25: North America Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
11.1.2 By Value- Forecast (2021)
Table 26: North America Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
11.2 North America Tuberculosis Vaccines Market
11.2.1 By Value-Actual(2015)
Table 27: North America Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
11.2.2 By Value- Forecast (2021)
Table 28: North America Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
11.3 North America Other Anti-Bacterial Vaccines Market
11.3.1 By Value-Actual(2015)
Table 29: North America Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
11.3.2 By Value- Forecast (2021)
Table 30: North America Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
11.4 North America Influenza Vaccines Market
11.4.1 By Value-Actual(2015)
Table 31: North America Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
11.4.2 By Value- Forecast (2021)
Table 32: North America Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
11.5 North America Hepatitis Vaccines Market
11.5.1 By Value – Actual ( 2011-2015)
Table 33: North America Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
11.5.2 By Value Forecast ( 2016-2021)
Table 34: North America Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
11.6 North America Other Anti-Viral Vaccines Market
11.6.1 By Value-Actual(2011-2015)
Table 35: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
11.6.2 By Value- Forecast (2016-2021)
Table 36: North America Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
11.7 US Anti-Infective Vaccines Market
11.7.1 By Value-Actual(2011-2015)
11.7.2 By Value- Forecast (2016-2021)
Table 37: US Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
11.8 US Anti-Bacterial Vaccines Market
11.8.1 By Value-Actual(2011-2015)
11.8.2 By Value- Forecast (2016-2021)
Table 38: US Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
11.9 US Anti-Viral Vaccines Market
11.9.1 By Value-Actual(2015)
11.9.2 By Value- Forecast (2021)
Table 39: US Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
11.10 Canada Anti-Infective Vaccines Market
11.10.1 By Value-Actual(2011-2015)
11.10.2 By Value- Forecast (2016-2021)
Table 40: Canada Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
11.13 North America Others Market
11.13.1 By Value-Actual(2011-2015)
11.13.2 By Value- Forecast (2016-2021)
Table 41: Canada Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
12. Europe Anti-Infective Vaccines Market
12.1 By Value-Actual(2015)
12.2 By Value- Forecast (2021)
Table 42: Canada Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Million)
12.3 Europe Anti-Bacterial Vaccines Market
12.3.1 By Value-Actual(2015)
12.3.2 By Value- Forecast (2021)
Table 43: North America Others Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
Table 44: Europe Anti-Infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Table 45: Europe Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
Table 46: Europe Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
Table 47: Europe Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
12.4 Europe Anti-Viral Vaccines Market
12.4.1 By Value-Actual(2015)
Table 48: Europe Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
12.4.2 By Value Forecast ( 2016-2021)
Table 49: Europe Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
13. Europe Anti-Infective Vaccines Market- By Disease
13.1 Europe Typhoid Vaccines Market
13.1.1 By Value-Actual(2015)
Table 50: Europe Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
13.1.2 By Value- Forecast (2021)
Table 51: Europe Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
13.2 Europe Tuberculosis Vaccines Market
13.2.1 By Value-Actual(2015)
Table 52: Europe Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
13.2.2 By Value- Forecast (2021)
Table 53: Europe Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
13.3 Europe Other Anti-Bacterial Vaccines Market
13.3.1 By Value-Actual(2015)
Table 54: Europe Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
13.3.2 By Value- Forecast (2021)
Table 55: Europe Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
13.4 Europe Influenza Vaccines Market
13.4.1 By Value-Actual(2015)
Table 56: Europe Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
13.4.2 By Value- Forecast (2021)
Table 57: Europe Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
13.5 Europe Hepatitis Vaccines Market
13.5.1 By Value – Actual ( 2011-2015)
Table 58: Europe Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
13.5.2 By Value Forecast ( 2016-2021)
Table 59: Europe Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
13.6 Europe Other Anti-Viral Vaccines Market
13.6.1 By Value-Actual (2011-2015)
Table 60: Europe Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
13.6.2 By Value- Forecast (2016-2021)
Table 61: Europe Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
13.7 UK Anti-Infective Vaccines Market
13.7.1 By Value-Actual(2011-2015)
13.7.2 By Value- Forecast (2016-2021)
Table 62: UK Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
13.8 UK Anti-Bacterial Vaccines Market
13.8.1 By Value-Actual(2011-2015)
13.8.2 By Value- Forecast (2016-2021)
Table 63: UK Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
13.9 UK Anti-Viral Vaccines Market
13.9.1 By Value-Actual(2015)
13.9.2 By Value- Forecast (2021)
Table 64: UK Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
13.10 France Anti-Infective Vaccines Market
13.10.1 By Value-Actual(2011-2015)
13.10.2 By Value- Forecast (2016-2021)
Table 65: France Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
13.11 France Anti-Bacterial Vaccines Market
13.11.1 By Value-Actual(2011-2015)
13.11.2 By Value- Forecast (2016-2021)
Table 66: France Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
13.12 France Anti-Viral Vaccines Market
13.12.1 By Value-Actual (2015)
13.12.2 By Value- Forecast (2021)
Table 67: France Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
13.13 Europe Others Market
13.13.1 By Value-Actual(2011-2015)
13.13.2 By Value- Forecast (2016-2021)
Table 68: Europe Others Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
14. APAC Anti-Infective Vaccines Market
14.1 By Value-Actual(2015)
Table 69: APAC Anti-infective Vaccines Market Size, By Value, 2011-2015 (USD Billion)
14.2 By Value- Forecast (2021)
Table 70: APAC Anti-infective Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
14.3 Europe Anti-Bacterial Vaccines Market
14.3.1 By Value-Actual(2015)
Table 71: APAC Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
14.3.2 By Value- Forecast (2021)
Table 72: APAC Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
14.4 Europe Anti-Viral Vaccines Market
14.4.1 By Value-Actual(2015)
Table 73: North America Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
14.4.2 By Value Forecast ( 2016-2021)
Table 74: APAC Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
15. APAC Anti-Infective Vaccines Market- By Disease
15.1 APAC Typhoid Vaccines Market
15.1.1 By Value-Actual(2015)
Table 75: APAC Typhoid Vaccines Market Size, By Value, 2011-2015 (USD Billion)
15.1.2 By Value- Forecast (2021)
Table 76: North America Typhoid Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
15.2 APAC Tuberculosis Vaccines Market
15.2.1 By Value-Actual(2015)
Table 77: APAC Tuberculosis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
15.2.2 By Value- Forecast (2021)
Table 78: APAC Tuberculosis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
15.3 APAC Other Anti-Bacterial Vaccines Market
15.3.1 By Value-Actual(2015)
Table 79: APAC Other Anti-Bacterial Vaccines Market Size, By Value, 2011-2015 (USD Billion)
15.3.2 By Value- Forecast (2021)
Table 80: APAC Other Anti-Bacterial Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
15.4 APAC Influenza Vaccines Market
15.4.1 By Value-Actual(2015)
Table 81: APAC Influenza Vaccines Market Size, By Value, 2011-2015 (USD Billion)
15.4.2 By Value- Forecast (2021)
Table 82: APAC Influenza Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
15.5 APAC Hepatitis Vaccines Market
15.5.1 By Value – Actual ( 2011-2015)
Table 83: APAC Hepatitis Vaccines Market Size, By Value, 2011-2015 (USD Billion)
15.5.2 By Value Forecast ( 2016-2021)
Table 84: APAC Hepatitis Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
15.6 APAC Other Anti-Viral Vaccines Market
15.6.1 By Value-Actual(2011-2015)
Table 85: North America Other Anti-Viral Vaccines Market Size, By Value, 2011-2015 (USD Billion)
15.6.2 By Value- Forecast (2016-2021)
Table 86: APAC Other Anti-Viral Vaccines Market Size, By Value, 2016E-2021F (USD Billion)
15.7 India Anti-Infective Vaccines Market
15.7.1 By Value-Actual(2011-2015)
15.7.2 By Value- Forecast (2016-2021)
Table 87: India Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
15.8 India Anti-Bacterial Vaccines Market
15.8.1 By Value-Actual(2011-2015)
11.8.2 By Value- Forecast (2016-2021)
Table 88: India Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
15.9 India Anti-Viral Vaccines Market
15.9.1 By Value-Actual(2015)
15.9.2 By Value- Forecast (2021)
Table 89: India Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
15.10 China Anti-Infective Vaccines Market
15.10.1 By Value-Actual(2011-2015)
15.10.2 By Value- Forecast (2016-2021)
Table 90: China Anti-infective Vaccines Market Size, By Value, 2011-2021(USD Billion)
15.11 China Anti-Bacterial Vaccines Market
15.11.1 By Value-Actual(2011-2015)
15.11.2 By Value- Forecast (2016-2021)
Table 91: China Anti-Bacterial Vaccines Market Size, By Value, 2011-2021(USD Billion)
15.12 China Anti-Viral Vaccines Market
15.12.1 By Value-Actual(2015)
15.12.2 By Value- Forecast (2021)
Table 92: China Anti-Viral Vaccines Market Size, By Value, 2011-2021(USD Billion)
15.13 APAC Others Market
15.13.1 By Value-Actual(2011-2015)
15.13.2 By Value- Forecast (2016-2021)
Table 93: APAC other’s Anti-Infective Vaccines Market Size, By Value, 2011-2021 (USD Billion)
16. ROW Anti-Infective Vaccines Market
16.1 By Value-Actual(2015)
Table 94: ROW Market Size, By Value, 2011-2015 (USD Million)
16.2 By Value- Forecast (2021)
Table 95: ROW Market Size, By Value, 2016E-2021F (USD Million)
17. Market Dynamics
17.1. Drivers
17.2. Challenges
17.3. Trends
18. Policy and Regulatory Landscape
19. Competitive Landscape
19.1. Company Profiles
19.1.1 Teva Pharmaceutical Industries Ltd.
19.1.2 Emergent Biosolutions
19.1.3 Sanofi Pasteur, Inc.
19.1.4 GlaxoSmithKline
19.1.5 Merck & Co., Inc.
19.1.6 CSL Limited
19.1.7 Astrazeneca
19.1.8 Pfizer
19.1.9 Serum Institute Of India Pvt. Ltd.
19.1.10 Protein Sciences Corporation

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report